Julen
Oyarzabal Santamarina
Investigador hasta 2018
Medical College of Wisconsin
Milwaukee, Estados UnidosPublicaciones en colaboración con investigadores/as de Medical College of Wisconsin (2)
2016
-
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease
Brain, Behavior, and Immunity, Vol. 57, pp. 94-105
2014
-
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
Neurobiology of Aging, Vol. 35, Núm. 11, pp. 2603-2616